Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BAL PHARMA vs HESTER BIOSCIENCES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BAL PHARMA HESTER BIOSCIENCES BAL PHARMA/
HESTER BIOSCIENCES
 
P/E (TTM) x 40.8 73.6 55.5% View Chart
P/BV x 2.3 4.2 53.5% View Chart
Dividend Yield % 1.1 0.6 190.3%  

Financials

 BAL PHARMA   HESTER BIOSCIENCES
EQUITY SHARE DATA
    BAL PHARMA
Mar-23
HESTER BIOSCIENCES
Mar-23
BAL PHARMA/
HESTER BIOSCIENCES
5-Yr Chart
Click to enlarge
High Rs1342,852 4.7%   
Low Rs631,416 4.5%   
Sales per share (Unadj.) Rs193.9312.7 62.0%  
Earnings per share (Unadj.) Rs1.732.9 5.1%  
Cash flow per share (Unadj.) Rs7.557.3 13.1%  
Dividends per share (Unadj.) Rs1.008.00 12.5%  
Avg Dividend yield %1.00.4 270.1%  
Book value per share (Unadj.) Rs40.7328.7 12.4%  
Shares outstanding (eoy) m15.698.51 184.4%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.56.8 7.5%   
Avg P/E ratio x59.264.7 91.4%  
P/CF ratio (eoy) x13.237.3 35.4%  
Price / Book Value ratio x2.46.5 37.4%  
Dividend payout %59.924.3 246.8%   
Avg Mkt Cap Rs m1,54918,152 8.5%   
No. of employees `000NANA-   
Total wages/salary Rs m553560 98.7%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m3,0422,661 114.3%  
Other income Rs m9154 6.1%   
Total revenues Rs m3,0522,814 108.4%   
Gross profit Rs m253548 46.1%  
Depreciation Rs m91207 44.1%   
Interest Rs m12393 132.1%   
Profit before tax Rs m47402 11.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m21121 17.6%   
Profit after tax Rs m26280 9.3%  
Gross profit margin %8.320.6 40.3%  
Effective tax rate %44.830.2 148.6%   
Net profit margin %0.910.5 8.2%  
BALANCE SHEET DATA
Current assets Rs m2,2822,276 100.2%   
Current liabilities Rs m2,0931,487 140.8%   
Net working cap to sales %6.229.7 20.9%  
Current ratio x1.11.5 71.2%  
Inventory Days Days847 16.2%  
Debtors Days Days1,128109 1,032.2%  
Net fixed assets Rs m8294,424 18.7%   
Share capital Rs m15785 184.4%   
"Free" reserves Rs m4812,712 17.7%   
Net worth Rs m6382,797 22.8%   
Long term debt Rs m3051,849 16.5%   
Total assets Rs m3,1106,700 46.4%  
Interest coverage x1.45.3 26.1%   
Debt to equity ratio x0.50.7 72.4%  
Sales to assets ratio x1.00.4 246.3%   
Return on assets %4.85.6 86.1%  
Return on equity %4.110.0 41.0%  
Return on capital %18.110.6 169.9%  
Exports to sales %66.411.6 572.2%   
Imports to sales %22.40-   
Exports (fob) Rs m2,020309 654.2%   
Imports (cif) Rs m683NA-   
Fx inflow Rs m2,020309 654.2%   
Fx outflow Rs m71639 1,847.1%   
Net fx Rs m1,305270 483.1%   
CASH FLOW
From Operations Rs m-18236 -7.8%  
From Investments Rs m-222-770 28.8%  
From Financial Activity Rs m244418 58.4%  
Net Cashflow Rs m4-116 -3.2%  

Share Holding

Indian Promoters % 47.1 44.3 106.3%  
Foreign collaborators % 4.2 9.5 43.9%  
Indian inst/Mut Fund % 0.1 0.4 30.2%  
FIIs % 0.1 0.4 30.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 48.8 46.3 105.4%  
Shareholders   15,060 13,450 112.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BAL PHARMA With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on BAL PHARMA vs HESTER PHARM

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

BAL PHARMA vs HESTER PHARM Share Price Performance

Period BAL PHARMA HESTER PHARM S&P BSE HEALTHCARE
1-Day -4.40% 1.12% 1.18%
1-Month -17.76% -1.37% -0.75%
1-Year 40.93% -14.68% 61.82%
3-Year CAGR 19.04% -9.87% 18.16%
5-Year CAGR 5.43% -2.54% 19.79%

* Compound Annual Growth Rate

Here are more details on the BAL PHARMA share price and the HESTER PHARM share price.

Moving on to shareholding structures...

The promoters of BAL PHARMA hold a 51.2% stake in the company. In case of HESTER PHARM the stake stands at 53.7%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of BAL PHARMA and the shareholding pattern of HESTER PHARM.

Finally, a word on dividends...

In the most recent financial year, BAL PHARMA paid a dividend of Rs 1.0 per share. This amounted to a Dividend Payout ratio of 59.9%.

HESTER PHARM paid Rs 8.0, and its dividend payout ratio stood at 24.3%.

You may visit here to review the dividend history of BAL PHARMA, and the dividend history of HESTER PHARM.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.